Bivalirudin versus heparin monotherapy in patients undergoing percutaneous coronary intervention: an analysis of acute adverse outcomes and cost.
Phase of Trial: Phase IV
Latest Information Update: 14 Sep 2015
At a glance
- Drugs Bivalirudin (Primary) ; Heparin
- Indications Coronary artery disease; Myocardial infarction
- Focus Adverse reactions
- 14 Sep 2015 New trial record